Edgewise Therapeutics, Inc. Common Stock (EWTX) Stock Price, Quote & AI Analysis

Live EWTX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Edgewise Therapeutics, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Edgewise Therapeutics, Inc. Common Stock (EWTX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

EWTX
Edgewise Therapeutics, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
28.150000
High
29.190000
Low
27.070000
Volume
80,815
VWAP
-
Market Cap
$2,980,196,417.10
52W Range
$10.60 - $30.48
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 19, 2026 Q4
After Hours
EPS Estimate: $-0.4445
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Edgewise Therapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Edgewise Therapeutics, Inc. Common Stock Overview

Company information

Company Overview

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.

Company Details
Market Cap
$3.06B
Shares Outstanding
105,868,435
Weighted Shares Outstanding
105,868,434
CEO
Kevin Koch
Address
1715 38TH ST, BOULDER, CO, 80301
Employees
136
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Edgewise Therapeutics, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...